Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial
- Aix, S.P.
- Ciuleanu, T.E.
- Navarro, A.
- Cousin, S.
- Bonanno, L.
- Smit, E.F.
- Chiappori, A.
- Olmedo, M.E.
- Horvath, I.
- Grohé, C.
- Farago, A.F.
- López-Vilariño, J.A.
- Cullell-Young, M.
- Nieto, A.
- Vasco, N.
- Gómez, J.
- Kahatt, C.
- Zeaiter, A.
- Carcereny, E.
- Roubec, J.
- Syrigos, K.
- Lo, G.
- Barneto, I.
- Pope, A.
- Sánchez, A.
- Kattan, J.
- Zarogoulidis, K.
- Waller, C.F.
- Bischoff, H.
- Juan-Vidal, O.
- Reinmuth, N.
- Dómine, M.
- Paz-Ares, L.
- Show all authors +
ISSN: 2213-2619, 2213-2600
Year of publication: 2023
Volume: 11
Issue: 1
Pages: 74-86
Type: Article